Every enterprise has AI agents. Few have given them access to the institutional knowledge that makes those agents useful — the curated context behind decisions, not just the documents. This is the architecture pattern for the missing layer between your existing infrastructure and the agents that need it.
Different domains, different systems, same outcome: when your experts need context, they spend hours searching scattered sources and still end up with partial, unverifiable answers.
Local markdown vaults have proven the model: structured files with metadata, bidirectional links, and AI agent access. The format is the strength. But the enterprise layer is entirely missing.
Shared vaults across teams, sites, and departments
Role-based read/write at file, folder, and tag level
Immutable history, diff, blame, regulatory retention
Any agent reads and writes via standard protocol
AI proposes structure; humans approve; context compounds
21 CFR Part 11 audit trails, ALCOA+ data integrity, e-signatures
Impact analysis, orphan detection, automated relationship discovery
Bidirectional sync: QMS, LIMS, CRM, data lake — not a silo
The Enterprise Knowledge Vault fills a specific gap. It does not replace the systems you already run. Understanding the boundaries matters more than the features.
Each of these platforms is excellent at what it does. None of them provides a curated, agent-accessible knowledge layer with structured context, provenance, and cross-domain linking. That is the gap.
The gold standard for GxP document management in pharma. Manages SOPs, protocols, regulatory submissions, and quality records with full 21 CFR Part 11 compliance.
Powerful ontology layer for connecting enterprise data. Excels at structured data integration, operational analytics, and decisioning workflows.
Widely used for team documentation. Good for project wikis, meeting notes, and general knowledge sharing across departments.
Your existing embeddings pipeline retrieves relevant chunks from documents. Valuable for grounding AI responses in your corpus.
Your enterprise already runs a data lake, vector databases, and RAG pipelines. Your people already use local markdown vaults. These are valuable — and insufficient. The Enterprise Knowledge Vault doesn’t replace them. It connects and extends them into a governed, curated knowledge layer where agents and humans drink from the same well.
.inbox/ until human-approved.
Five are the recognized requirements for any enterprise vault. Three more are critical for regulated industries and adoption at scale — gaps that surface only when you try to ship this in production.
Per-vault cloud storage with concurrent editing. Multi-vault isolation by tenant, real-time change sync via event bus. Designed to scale across sites and departments.
All domainsSix-tier RBAC: vault admin, curator, contributor, reviewer, reader, agent. File, folder, and tag-level policies. Confidentiality controls per note. Agent writes go to inbox for human review.
Brand teams need this for LOE strategy docsEvery write creates an immutable version. Diff between any two versions. Blame attribution for every line. Regulatory-grade retention (7+ years).
Critical for GxP deviation investigationsThree interfaces: REST API (universal), MCP Server (agent-native), and tool-use for hosted AI. Four core tools: read, search, write, traverse. Protocol-agnostic design — MCP today, whatever wins tomorrow.
The unlock for agent-accessible knowledgeFive-stage pipeline: Extract → Structure → Contextualize → Propose → Quality Gate. GxP notes go to inbox; non-GxP can auto-commit. Tiered review model to prevent curator bottleneck (see Curation at Scale).
How dose rationale gets captured before anyone rotates21 CFR Part 11 electronic records with e-signatures bound via two-factor auth. ALCOA+ data integrity. GAMP 5 validation lifecycle (IQ/OQ/PQ). Write-once immutable storage with tamper-proof audit trail. Validated change control process for system updates. Not a feature you bolt on — it shapes the entire architecture from day one.
Pre-approval inspections require thisBeyond simple wikilinks: orphan note detection, freshness scoring, and impact analysis (“what else changes if we change this?”). Cross-domain relationship discovery is the hardest problem in this architecture — it requires deep domain ontology modeling and is a multi-phase investment, not a one-sprint feature.
Endpoint change → downstream impacts surfacedBidirectional connectors to QMS, LIMS, CRM, data lakes, and regulatory systems. The vault can’t be another silo. Knowledge flows in from batch records and out to compliance reports. Adoption dies without this.
Integration is the adoption acceleratorThe same three people. The same questions. But now their AI agents have access to curated, structured, permissioned institutional knowledge — not scattered documents.
Protocol Intelligence Vault protocols/ ASSET-001-NSCLC-Phase3-v3.2.md # phase: 3, indication: NSCLC, status: active rationale/ dose-selection-200mg-Q3W.md # linked to PK/PD model + safety review endpoint-switch-PFS-to-OS.md # FDA feedback + competitive pressure amendments/ amendment-03-futility-interim.md # why interim moved to 75% enrollment regulatory/ FDA-Type-B-meeting-2025-06.md # co-primary acceptable per Division competitive/ NSCLC-IO-landscape-2026-Q2.md # vs KEYTRUDA, TECENTRIQ positioning .inbox/ DSMB-minutes-extraction-2026-Q2.md # agent-proposed, awaiting curator review
Brand Competitive Intelligence Vault brand/ ELIQUIS-position-2026-Q2.md # TA: cardiology, market_share: 48% competitors/ XARELTO/label-update-2026-03.md # VTE prophylaxis extension impact biosimilar-pipeline.md # ANDA timelines, IP litigation status payer/ express-scripts-2026-formulary.md # preferred over XARELTO in Part D kol/ Dr-Braunwald-sentiment.md # congress talk, stated preferences strategy/ LOE-strategy-2028.md # confidentiality: executive_only .inbox/ iqvia-weekly-market-share-W20.md # auto-ingested from data lake connector
Process Knowledge & Deviation Intelligence Vault processes/upstream/ bioreactor-pH-control.md # setpoint: 7.0, range: 6.9-7.1, CPP: yes deviations/ DEV-2025-0847-pH-excursion.md # root_cause: probe drift after 14-day campaign capa/ CAPA-2025-312-calibration-interval.md # corrective: 14 → 7 day calibration interval tribal-knowledge/ campaign-length-limits.md # why 21 days not 28 (2022 deviation cluster) tech-transfer/ chromatography-resin-switch.md # supply chain risk + comparability data .inbox/ batch-1247-parameter-extraction.md # auto-extracted from MES on batch close
If every auto-ingested batch record, IQVIA feed, and regulatory update requires human review, curators become the bottleneck. The architecture addresses this with tiered review — not all knowledge carries equal risk.
Non-GxP, low-risk knowledge from trusted pipelines with high-confidence extraction. Examples: public regulatory guidance updates, market share data from validated feeds, congress abstract summaries. Agent commits directly; human audit is sampling-based (10–15%).
Medium-risk knowledge where the agent structures and proposes, but a curator does a pass/fail review (not a full rewrite). Target SLA: 48 hours. Escalation trigger if inbox exceeds threshold. Examples: competitive intelligence summaries, internal meeting action items, field medical notes.
High-risk, regulated knowledge requiring full human verification, e-signature, and audit trail. Examples: deviation root causes, protocol rationale, dose selection decisions, CAPA effectiveness. No auto-commit. Full review with subject-matter-expert sign-off.
Two production systems that follow the vault pattern: curated, structured knowledge that AI agents read, search, traverse, and cite. These validate the domain knowledge model. They do not yet prove the full enterprise platform described above — they are the starting point, not the finish line.
ProtoCheckA curated vault of 500+ regulatory citations across FDA, EMA, ICH, and WHO — structured as rules with YAML metadata, linked to source regulations, and traversed by AI agents that check clinical trial protocols for compliance gaps. Every finding traces back through the vault to its regulatory source.
CiteTrace63,000+ enriched FDA 483 observation vectors mapped to 503 CFR sections and 96 ICH guidelines. Agents query the vault to surface facility risk scores, root-cause patterns, and regulatory precedent — every answer linked to its source in the FDA’s own corpus. The vault compounds as new 483s are ingested and auto-linked.
Phase 0 establishes the vault standards baseline. Then four build phases deliver on those standards, each increasing in complexity. This is a multi-year architecture investment, not a quarterly project. We show estimated timelines because you deserve to plan with real numbers.
Total estimated timeline: 18–30 months from Phase 0 through Phase 4, depending on enterprise size, regulatory requirements, and the number of domain vaults. This is a significant architecture investment. Phase 3 (GxP compliance) alone requires a validated system lifecycle with IQ/OQ/PQ, SOPs for system use, and a change control process that survives FDA inspection. Cross-domain knowledge graph intelligence (Phase 4) is an open research problem in ontology alignment — we scope it as iterative, not deterministic. We believe the investment is justified by the scale of the knowledge loss problem. But we also believe you deserve honest timelines, not optimistic ones.
We’ve designed the enterprise knowledge vault architecture, shipped production domain vaults with agent-accessible APIs and evidence provenance, and validated the curation model with expert calibration. What we bring to your implementation: pharma domain expertise, proven vault patterns, and an honest assessment of what it takes to go enterprise.